| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.09 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |